Stride Inc director awarded 4,097 restricted shares of stock

Stride, Inc. reported that a director received a grant of 4,097 shares of restricted common stock on December 4, 2025 at a price of $0 per share.

Rhea-AI Filing Summary

Stride, Inc. reported that a director received a grant of 4,097 shares of restricted common stock on December 4, 2025 at a price of $0 per share. Following this grant, the director beneficially owns 6,551 shares of Stride common stock in total, held directly. These restricted shares will vest on the earlier of December 4, 2026 or the next annual meeting of Stride’s stockholders, aligning the director’s compensation with the company’s future performance.

Insider Trade Summary

Grant/Award: 4,097 shares

Grant/Award 1 txn

Insider KNOWLING ROBERT E JR

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	4,097	$0.00	$0.00

Holdings After Transaction: Common Stock — 6,551 shares (Direct)

Footnotes (1)

1. F1. These shares are restricted and will vest on the earlier of (a) December 4, 2026, or (b) the next annual meeting of the stockholders of Stride, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Stride, Inc. (LRN) disclose in this report?

A director of Stride, Inc. received a grant of 4,097 shares of restricted common stock on December 4, 2025 at a price of $0 per share.

How many Stride, Inc. (LRN) shares does the director own after this grant?

After the restricted stock grant, the director beneficially owns 6,551 shares of Stride, Inc. common stock, all held directly.

When do the director’s restricted Stride, Inc. (LRN) shares vest?

The 4,097 restricted shares vest on the earlier of December 4, 2026 or the next annual meeting of the stockholders of Stride, Inc..

What type of security did the Stride, Inc. (LRN) director receive?

The director received restricted shares of common stock of Stride, Inc., which are subject to vesting conditions tied to time and the next annual meeting.

Was any cash paid for the Stride, Inc. (LRN) restricted stock grant?

No cash was paid for this award; the restricted shares were granted at a reported price of $0 per share as part of the director’s equity compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/08/2025 - 05:07 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KNOWLING ROBERT E JR

(Last) (First) (Middle)

11720 PLAZA AMERICA DRIVE

9TH FLOOR

(Street)

RESTON VA 20190

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Stride, Inc. [ LRN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/04/2025		A		4,097(1)	A	$0	6,551	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares are restricted and will vest on the earlier of (a) December 4, 2026, or (b) the next annual meeting of the stockholders of Stride, Inc.

	/s/ John C. Grothaus, Attorney-in-fact	12/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.